Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05291156
Title CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Campania Luigi Vanvitelli

colorectal adenocarcinoma



Avelumab + Cetuximab

Age Groups: senior | adult
Covered Countries ITA

Additional content available in CKB BOOST